cultured meat

  • DATABASE (40)

  • ARTICLES (76)

    • DATABASE (40)
    • ARTICLES (76)
  • Sort by
    • Relevance
    • Date

Shannon Falconer graduated with a master’s in botany at the University of Vancouver in 2006. She also completed a PhD in biochemistry at The McMaster University in 2014. She went on to work as a postdoctoral researcher at Stanford University until 2016 when she decided to become the CEO and co-founder of biotech startup Because Animals. She also led the biotech’s R&D team to develop plant-based nutritional cookies and treats for dog and cats. Because Animals now aims to produce the world’s first cell-based cultured meat products for pets.

Founded in 2013 and based in Silicon Valley, AgFunder invests in agrifood tech startups globally with the mission of “investing in technologies to rapidly transform our food and agriculture system.” The VC firm has already built a global ecosystem of 85,000+ members and subscribers, which helps grow and scale its portfolio companies. It recently established the New Carnivore fund to invest in startups working to create animal-free protein alternatives including plant-based meat and cultured meat. In 2019, AgFunder and the Australian agrifood accelerator Rocket Seeder co-launched GROW Impact Accelerator in Singapore to accelerate seed and Series A agritech startups from Southeast Asia.

Daan Luining is the Dutch co-founder and CTO at cell-based meat startup Meatable, the first to claim a highly scalable culture technology, where he has worked since 2018.  He is also a research director at the Cellular Agriculture Society in Leiden, a joint initiative for cell-based startups to share knowledge and to collaborate on projects to further scale the sector. Luining is also on the board of directors at the not-for-profit Cultured Meat Foundation that promotes sector innovation. His past posts have all been in the area of research, either as a researcher or a technician, and at the same time as completing studies. His last job was as a research strategist at New York-based New Harvest, a callular food rsearch funding body, where he worked for a year and met Dr. Kotter, the inventor of Meatable’s cellular technology. His research positions from 2009–15 were in the area of cell culture,  mass spectrometry and DNA sequencing at the Maastricht University, University Medical Center Amsterdam, Utrecht University and Leiden University. Luining holds a master’s in biological sciences from Leiden University in the Netherlands. 

Founded in Amsterdam in 2014, Rubio Impact Ventures was formerly known as Social Impact Ventures. The VC currently invests in sustainability-focused startups that are predominantly based in the Netherlands and north-western Europe. It currently has 27 portfolio companies including fair coffee brand Wakuli and cultured meat pioneer Masa Meat. The “Rubicon crossing” VC has just raised €110m for its second impact fund, Rubio Fund 2, in October 2021.Recent investments include participation in the $43m Series B round of food-sharing app OLIO in September 2021 and the €3.6m seed round in July 2021 for Portuguese Arborea that uses micro-organisms in biotech for foodtech applications.

Founded in 2012, Purple Orange’s objective is to support the transition away from animals in the food chain, supporting early-stage food and biotech companies across the globe with a focus on alternative proteins and cellular agriculture. It currently has 12 startups from different nations in its portfolio. Its most recently disclosed investments have been in the December 2020 pre-seed round of Chinese cultured meat startup CellX and in the November 2020 $500,000 pre-seed round of Swedish plant-based food vending startup VEAT. 

Founded in September 2019 by Patrick Morris, Eat Beyond went public on the Canadian Securities Exchange in November 2020. The company’s shares are also traded on the Frankfurt Exchange in Germany and OTC Markets in the US. Morris had worked in capital markets for over 15 years and wanted to find a solution to help retail investors access the emerging markets of alt-proteins and other future food sectors.First of its kind in Canada, the Eat Beyond Global Investment Fund focuses on four key areas: meat, seafood, eggs, and dairy. It also participates in cell agriculture and other experimental projects. Current investments include foodtechs and alt-food source companies working on plant-based proteins, fermented proteins, cultured proteins, agriculture and consumer packaged goods.

The GlassWall Syndicate is a US investment group comprising venture capitalists, foundations, trusts, non-profits and individual investors. The VC members include Blue Horizon, Veg Invest and New Crop Capital.The syndicate funds are mostly invested in foodtech companies like Mosa Meat and Beyond Meat that are currently disrupting the traditional global food industry.

Founded in 2017 in Hong Kong, Happiness Capital invests in seed to growth stage companies in the US, Europe, Israel, and China, with a focus on issues affecting global happiness within the areas of citizen trust, food, health, climate change, and reduced inequalities. It hosts its own annual contest, the Super Happiness Challenge , a global open innovation contest to fund individuals and startups with ideas and new products or services that tapped into unmet needs to achieve happiness, with a possible $1m in total investment on offer. The VC currently has 37 startups in its portfolio, around half of which are in foodtech and agtech. Its most recent investments include leading the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions, and co-leading the $29m February 2021 Series A round of Israeli 3D printed alt-meat startup Redefine Meat.

Established in 2015, Unovis Asset Management is a New York-based investor focussed on the alternative protein sector. It has raised two funds to date, the New Crop Capital Trust and The Alternative Protein Fund. It aims to transform the global food system by investing in solutions that facilitate sustained behavioral change and eliminate the consumption of animal protein products. It partners with entrepreneurs developing innovative plant-based and cultivated replacements to animal products, including meat, seafood, dairy and eggs. It currently has 33 companies in its portfolio and has managed three exits to date including Beyond Meat. Its recent investments include the undisclosed convertible note round of Spanish plant-based meat startup Foods for Tomorrow in May 2020 and in the $28m seed round of US plant-based startup Alpha Foods in February 2020.

Based in London, CPT Capital is the venture arm of private equity pioneer Jeremy Coller's private family office. Coller is the founder of Europe’s first private equity for secondaries in 1990. The British philanthropist has also established several business schools and the Jeremy Coller Foundation that aims to eliminate factory farming. In 2017, CPT Capital was founded to disrupt the food industry with investments in the alt-protein sector to create the “future of food and materials” like plant-based, recombinant and cell-cultured proteins.

Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.

Krijn De Nood is the Dutch co-founder and CEO at cell-based meat startup Meatable, the first to claim a highly scalable culture technology with the use of pluripotent stem cells, where he has worked since 2018. He previously worked at McKinsey for six-and-a-half years in Amsterdam, New York and in Kenya. Prior to that, he worked as an equity derivatives trader at derivative trading company All Options after a short stint at Barclays Capital.De Nood holds two first degrees from the University of Amsterdam, in philosophy and in economics and finance. 

TurtleTree Labs will license its technology for creating natural ingredients found in human milk to dairy and infant formula companies to produce full-composition liquid milk.

Capital V is a French rural-based investor that only invests in solutions that facilitate sustained behavioral change and eliminate the consumption of animal products. Its investments range from €10,000 to €1m and currently has 20 startups in its portfolio, mainly plant-based meat makers.In 2020, it announced its participation in Pitch & Plant 2020, the global investment competition by Vevolution for plant-based and animal-free startups, offering £100,000 to finalists. Among its recent investments are participation in the extended 2020 seed round of THIS, a UK-based plant-based meat startup that has raised over £6m to date and, in August 2020, in vegan confectionary manufacturer, Livia’s that has raised over £1m so far.

Bezos-backed Chile’s first unicorn uses proprietary AI algorithm to analyze food molecules to produce plant-based meat and dairy products that taste like the original.

Sorry, we couldn’t find any matches for“cultured meat”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.